142 related articles for article (PubMed ID: 34672431)
1. Prognostic impact of hepatitis B virus infection in patients with primary cervical cancer.
Feng X; Lu H; Wei Y; Guan M; Wang J; Liu C; Shen T; Chen Q; Rao Q
Cancer Med; 2021 Dec; 10(23):8310-8319. PubMed ID: 34672431
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B Virus Infection is a Prognostic Biomarker for Better Survival in Operable Esophageal Cancer: Analysis of 2,004 Patients from an Endemic Area in China.
Zou J; Chen J; Xie X; Liu Z; Cai X; Liu Q; Wen J; Zhang S
Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1028-1035. PubMed ID: 30872314
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Hepatitis B Virus Infection in Very Young Patients With Curatively Resected Breast Cancer: Analyses From an Endemic Area in China.
Li N; Zhong QQ; Yang XR; Wang QC; Zhang DT; Zheng S; Yang L; Wei WD
Front Oncol; 2020; 10():1403. PubMed ID: 32850453
[No Abstract] [Full Text] [Related]
4. Hepatitis B virus infection specially increases risk of liver metastasis in breast cancer patients: a propensity-matched analysis.
Yu P; Liu P; Li N; Xie X; Tang H; Wu J; Kong Y; Xie X; Ye F
Transl Cancer Res; 2020 Mar; 9(3):1506-1517. PubMed ID: 35117498
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic antiviral therapy in allogeneic hematopoietic stem cell transplantation in hepatitis B virus patients.
Liao YP; Jiang JL; Zou WY; Xu DR; Li J
World J Gastroenterol; 2015 Apr; 21(14):4284-92. PubMed ID: 25892880
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B Virus Infection Is Associated with Poor Prognosis in Patients with Advanced Non Small Cell Lung Cancer.
Peng JW; Liu DY; Lin GN; Xiao JJ; Xia ZJ
Asian Pac J Cancer Prev; 2015; 16(13):5285-8. PubMed ID: 26225667
[TBL] [Abstract][Full Text] [Related]
7. The prognostic role of HBV infection in chronic lymphocytic leukemia.
Liang JH; Gao R; Dai JC; Gale RP; Li W; Fan L; Hu ZB; Xu W; Li JY
J Cancer Res Clin Oncol; 2018 Jul; 144(7):1309-1315. PubMed ID: 29761374
[TBL] [Abstract][Full Text] [Related]
8. Effects of hepatitis B virus infection and antiviral therapy on the clinical prognosis of nasopharyngeal carcinoma.
Weng JJ; Wei JZ; Li M; Lu JL; Qin YD; Jiang H; Qu SH
Cancer Med; 2020 Jan; 9(2):541-551. PubMed ID: 31774249
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of chronic hepatitis B virus infection in patients with nasopharyngeal carcinoma: analysis of 1301 patients from an endemic area in China.
Liu X; Li X; Jiang N; Lei Y; Tang LL; Chen L; Zhou GQ; Sun Y; Yue D; Guo R; Mao YP; Li WF; Liu LZ; Tian L; Lin AH; Ma J
Cancer; 2014 Jan; 120(1):68-76. PubMed ID: 24114075
[TBL] [Abstract][Full Text] [Related]
10. Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B Infection.
Omichi K; Shindoh J; Yamamoto S; Matsuyama Y; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1034-40. PubMed ID: 26350363
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical Cancer.
Jiang Y; Gu H; Zheng X; Pan B; Liu P; Zheng M
Pathol Oncol Res; 2021; 27():1609946. PubMed ID: 34992504
[No Abstract] [Full Text] [Related]
12. Prognostic value of chronic hepatitis B virus infection in patients with breast cancer in a hepatitis B virus endemic area.
Xiao W; Zhou Y; Yu P; Yang A; Zheng S; Tang H; Xie X
Ann Transl Med; 2020 Mar; 8(5):180. PubMed ID: 32309327
[TBL] [Abstract][Full Text] [Related]
13. The expression of hepatitis B virus surface antigen in 120 Hodgkin's lymphoma patients.
Qiu MZ; Ruan DY; Wang ZQ; Luo HY; Teng KY; Xia ZJ; Lu Y; Huang HQ; Jiang WQ; Xu RH
Chin J Cancer; 2010 Aug; 29(8):735-40. PubMed ID: 20663320
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus infection status is an independent risk factor for multiple myeloma patients after autologous hematopoietic stem cell transplantation.
Li J; Liu J; Huang B; Zheng D; Chen M; Zhou Z; Xu D; Zou W
Tumour Biol; 2013 Jun; 34(3):1723-8. PubMed ID: 23436046
[TBL] [Abstract][Full Text] [Related]
15. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus infection: a favorable prognostic factor for intrahepatic cholangiocarcinoma after resection.
Zhou HB; Wang H; Li YQ; Li SX; Wang H; Zhou DX; Tu QQ; Wang Q; Zou SS; Wu MC; Hu HP
World J Gastroenterol; 2011 Mar; 17(10):1292-303. PubMed ID: 21455328
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival.
Chen KL; Chen J; Rao HL; Guo Y; Huang HQ; Zhang L; Shao JY; Lin TY; Jiang WQ; Zou DH; Hu LY; Wirian ML; Cai QQ
Chin J Cancer; 2015 May; 34(5):225-34. PubMed ID: 26058465
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus reactivation in cancer patients with positive Hepatitis B surface antigen undergoing PD-1 inhibition.
Zhang X; Zhou Y; Chen C; Fang W; Cai X; Zhang X; Zhao M; Zhang B; Jiang W; Lin Z; Ma Y; Yang Y; Huang Y; Zhao H; Xu R; Hong S; Zhang L
J Immunother Cancer; 2019 Nov; 7(1):322. PubMed ID: 31753012
[TBL] [Abstract][Full Text] [Related]
19. Clinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma.
Wang F; Xu RH; Luo HY; Zhang DS; Jiang WQ; Huang HQ; Sun XF; Xia ZJ; Guan ZZ
BMC Cancer; 2008 Apr; 8():115. PubMed ID: 18433487
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin.
Deng L; Song Y; Young KH; Hu S; Ding N; Song W; Li X; Shi Y; Huang H; Liu W; Zheng W; Wang X; Xie Y; Lin N; Tu M; Ping L; Ying Z; Zhang C; Sun Y; Zhu J
Oncotarget; 2015 Sep; 6(28):25061-73. PubMed ID: 26314957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
